Literature DB >> 1909053

Alterations in oral microflora and pathogenesis of acute oral infections during remission-induction therapy in patients with acute myeloid leukaemia.

O J Bergmann1.   

Abstract

To investigate changes in the aerobic and facultatively anaerobic oral microflora during remission-induction chemotherapy in patients with acute myeloid leukaemia, 10 consecutive patients were studied during a period of 28 days. During antineoplastic treatment, the concentration of microorganisms in saliva doubled from day 0 to day 2, presumably as a result of a concurrent 64% decrease in the salivary flow rate. No changes in the relative proportion of individual microorganisms or acquisition of new microorganisms occurred during antineoplastic treatment. During antibacterial treatment, which was subsequently initiated in all patients, a 100-fold decline occurred in the median salivary concentration of microorganisms within the first 7 days. During this period, members of the normal flora became undetectable in 5 patients, and Enterobacteriaceae, Enterococcus faecalis or Candida spp. became parts of the quantitatively predominant oral microflora in 7 patients. Apart from Candida spp., these potentially pathogenic microorganisms were acquired only after the initiation of the antibacterial treatment. After termination of the antibacterial treatment, the median concentration of microorganisms increased again to the original level and normal flora became reestablished within a period of 8 days. Clinically, 10/20 acute oral infections emerged before day 8, i.e. within the period with increased concentrations of microorganisms in saliva. Specifically, the clinical diagnosis of acute oral candidiasis was associated with a rise in the concentration of Candida spp. above a critical value of 1,000 CFU/ml. Herpes simplex virus (HSV) type 1 was detected in 4/9 HSV-seropositive patients on days 14 and 21, and HSV-1 was in all 4 cases isolated simultaneously with the emergence of an intraoral ulcer. The results suggest that chemotherapy-induced xerostomia plays a significant role in the pathogenesis of acute oral infections and transmission of potentially pathogenic microorganisms is of importance mainly after initiated antibiotic treatment in these patients.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1909053     DOI: 10.3109/00365549109024323

Source DB:  PubMed          Journal:  Scand J Infect Dis        ISSN: 0036-5548


  7 in total

1.  Chemotherapy-induced oral mucositis and associated infections in a novel organotypic model.

Authors:  T Sobue; M Bertolini; A Thompson; D E Peterson; P I Diaz; A Dongari-Bagtzoglou
Journal:  Mol Oral Microbiol       Date:  2018-02-20       Impact factor: 3.563

Review 2.  A systematic review of salivary gland hypofunction and xerostomia induced by cancer therapies: prevalence, severity and impact on quality of life.

Authors:  S B Jensen; A M L Pedersen; A Vissink; E Andersen; C G Brown; A N Davies; J Dutilh; J S Fulton; L Jankovic; N N F Lopes; A L S Mello; L V Muniz; C A Murdoch-Kinch; R G Nair; J J Napeñas; A Nogueira-Rodrigues; D Saunders; B Stirling; I von Bültzingslöwen; D S Weikel; L S Elting; F K L Spijkervet; M T Brennan
Journal:  Support Care Cancer       Date:  2010-03-17       Impact factor: 3.603

Review 3.  Oral candidiasis.

Authors:  A Akpan; R Morgan
Journal:  Postgrad Med J       Date:  2002-08       Impact factor: 2.401

4.  Prevention and management of antineoplastic therapy induced oral mucositis.

Authors:  Afshan Bey; Syed S Ahmed; Bilal Hussain; Seema Devi; Sarwat H Hashmi
Journal:  Natl J Maxillofac Surg       Date:  2010-07

5.  Investigation of the oral infections and manifestations seen in patients with advanced cancer.

Authors:  Lihua Xu; Hualin Zhang; Jinsong Liu; Xiaowei Chen
Journal:  Pak J Med Sci       Date:  2013-09       Impact factor: 1.088

6.  Molecular Characteristics of High-Dose Melphalan Associated Oral Mucositis in Patients with Multiple Myeloma: A Gene Expression Study on Human Mucosa.

Authors:  Mette Marcussen; Julie Støve Bødker; Heidi Søgaard Christensen; Preben Johansen; Søren Nielsen; Ilse Christiansen; Olav Jonas Bergmann; Martin Bøgsted; Karen Dybkær; Mogens Vyberg; Hans Erik Johnsen
Journal:  PLoS One       Date:  2017-01-04       Impact factor: 3.240

Review 7.  Host impairments in patients with neoplastic diseases.

Authors:  J Peter Donnelly; Nicole M A Blijlevens; Walter J F M van der Velden
Journal:  Cancer Treat Res       Date:  2014
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.